Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Radiofrequency Ablation in Treating Patients With Early Invasive Breast Cancer or Ductal Carcinoma in Situ

This study has been completed.
Sponsor:
Collaborator:
National Cancer Institute (NCI)
Information provided by:
University of California, Davis
ClinicalTrials.gov Identifier:
NCT00388115
First received: October 12, 2006
Last updated: March 25, 2010
Last verified: March 2010
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: May 2007
  Primary Completion Date: May 2007 (Final data collection date for primary outcome measure)